2027 Co-op Cell Medicines Research & Development

Regeneron Pharmaceuticals, Inc (USA); Cambridge (MA); On-site; USD 25,000 - 70,000; Full time

Job summary

Regeneron Pharmaceuticals, Inc (USA) is seeking multiple co-ops for the Regeneron Cell Medicines (RCM) team in Cambridge, MA and Seattle, WA. These full-time, onsite positions run January–August, May/June–December, or August–December.

Pay ranges by education level, with an hourly rate between $17.90 and $50.90, reflecting education stage and program. Co-ops will assist with in vitro safety testing, antigen expression studies, and viral-vector production for cell engineering.

Qualifications

• Enrollment in an Undergraduate or Graduate degree program and returning to school after the position.
• Must commit to 40 hours per week for the specified co-op period.
• Preferred GPA of 3.0 or higher.

Responsibilities

• Support in vitro safety and efficacy testing of cell therapy candidates.
• Develop tumor antigen expression and flow cytometry methods.
• Contribute to viral-vector production and process development for cell engineering.
• Support high-throughput protein production activities.
• Contribute to analytical method development supporting GMP manufacturing.
• Support digital-transformation initiatives for manufacturing operations.
• Document experimental procedures and results.
• Collaborate with scientists across the cell therapy team.

Skills

Leadership

Campus activities

Team collaboration

Communication

Education

Undergraduate or Graduate degree

Tools

Flow cytometry

Job description

At Regeneron, we use science and innovation to develop life‑changing medicines for people with serious diseases. Regeneron is currently seeking multiple 2027 Co‑ops to join our Regeneron Cell Medicines (RCM) team, Regeneron's cell therapy unit developing next‑generation T‑cell therapies for cancer. These positions offer the opportunity to contribute to a fast‑growing, science‑driven organization making a meaningful difference to patients worldwide.

When & where:

Location: Cambridge, MA / Seattle, WA
Timeframe: Our Co‑op positions are full‑time and onsite from January‑August (Spring‑Summer), May/June‑December (Summer‑Fall), and August‑December (Fall).
Pay: Intern and Co‑op pay ranges are determined by level of education (year in school) and degree program. The hourly rate range for these locations is: $17.90-$50.90 per hour.

What you’ll do:

• Support in vitro safety and efficacy testing of cell therapy candidates
• Develop tumor antigen expression and flow cytometry methods
• Contribute to viral‑vector production and process development for cell engineering
• Support high‑throughput protein production activities
• Contribute to analytical method development supporting Good Manufacturing Practice (GMP) manufacturing
• Support digital‑transformation initiatives for manufacturing operations
• Document experimental procedures and results
• Collaborate with scientists across the cell therapy team

Let’s find out if we’re a fit:

• Must be enrolled in, or accepted to, an academic program pursuing an Undergraduate or Graduate degree (and be returning to school the semester following the position or graduating after the position)
• Must be able to commit to 40 hours per week from January‑August, May/June‑December, or August‑December
• Demonstrated leadership in areas such as campus activities, clubs, sports, current or previous work, or within the community
• Preferred Cumulative GPA of 3.0 or higher

We are committed to building a workplace with an inclusive culture. Regeneron is an equal opportunity employer and all qualified applicants will receive consideration for employment without regard to race, color, religion or belief (or lack thereof), sex, sexual orientation, gender identity or expression, gender reassignment, marital or civil partnership status, civil status, pregnancy or parental status, age, disability, nationality, citizenship status, ethnic or national origin, membership of the Traveler community, familial status, genetic information, military or veteran status, or any other characteristic protected under applicable law. Where required, we will provide reasonable accommodation to applicants with known disabilities or chronic illnesses during the recruitment process, unless such accommodation would impose undue hardship. Where necessary, we disclose salary ranges for roles in all countries in which we operate. The final offer will be determined within the relevant range based on the country of employment, specific role level, and your skills and experience. In some countries, collective bargaining agreements (CBAs) may apply and influence certain elements of pay or benefits. Regeneron offers a competitive and comprehensive total rewards package which may include, depending on country and role: annual bonuses or other incentive plans, equity awards, pension or retirement benefits, 401(k) company match, health and wellness programs, fitness centers, insurance benefits (e.g. medical, dental, vision, life and disability), paid time off, and family support benefits. For additional information about Regeneron benefits in the U.S., please visit https://careers.regeneron.com/en/working-at-regeneron/total-rewards/. For other locations, additional information will be provided during the recruitment process. Please be advised that at Regeneron, we believe we do our best work when we are together. For that reason, many roles are required to be performed on‑site. As part of the recruitment process, certain background checks may be conducted in accordance with the laws of the country where the position is based. The purpose of such checks is to verify certain information prior to the commencement of employment such as identity, right to work and educational qualifications. For jobs in Canada: this posting is for an existing position. Regeneron is a leading biotechnology company that invents life‑transforming medicines for people with serious diseases. Founded and led for over 30 years by physician‑scientists, our unique ability to repeatedly and consistently translate science into medicine has led to nine FDA‑approved treatments and numerous product candidates in development, almost all of which were homegrown in our laboratories. Our medicines and pipeline are designed to help patients with eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, neurology, infectious diseases and rare diseases. Regeneron is also proud of award‑winning culture of innovation, being recognized as a Great Place to Work in 2021, Fast Company’s Best Workplace for Innovators in 2020, and Forbes JUST companies in 2020, among others.